Sept 26 (Reuters) - Cereno Scientific AB  CRNOSb.TE :
    * CERENO SCIENTIFIC RECEIVES APPROVAL FOR THE START OF A
PHASE II
CLINICAL TRIAL IN RUSSIA
    * COMPANY INTENDS TO START STUDY FIRST HALF OF 2020 WITH
INTENTION
OF DEMONSTRATING CS1'S PREVENTATIVE EFFECT AGAINST FORMATION OF
BLOOD CLOTS AFTER ORTHOPEDIC SURGERY
    * IN MAY, CERENO SCIENTIFIC ALSO SUBMITTED AN APPLICATION TO
START
STUDY WITH CS1 TO AUTHORITIES IN BULGARIA
    * CERENO SCIENTIFIC EXPECTS APPROVAL FOR PHASE II STUDY BY
BULGARIAN AUTHORITIES THIS FALL

Source text for Eikon:  ID:nWkr324pSP 
Further company coverage:  CRNOSb.TE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com;))